| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-07-29 | TPM®/Oxymorphone | moderate to severe chronic pain |
2a | Phosphagenics (Australia) | CNS diseases |
| 2014-07-29 | TPM®/Oxycodone patch | peripheral neuropathic pain |
2a | Phosphagenics (Australia) | CNS diseases |
| 2014-07-29 | PROHEMA® (16, 16-dimethyl prostaglandin E2, or dmPGE2, modulated cord blood) | treatment of pediatric patients undergoing hematopoietic stem cell (HSC) transplantation for the treatment of inherited metabolic disorders (IMDs) | 1b | Fate Therapeutics (USA - CA) | Metabolic diseases - Trasplantation - Rare diseases |
| 2014-07-28 | simeprevir (TMC435) and sofosbuvir (GS7977) | genotype 1 chronic hepatitis C virus |
2 | Medivir (Sweden) Janssen Pharmaceutical (J&J - USA) | Infectious diseases |
| 2014-07-28 | ThermoDox® (encapsulated doxorubicin) in combination with radiofrequency ablation | primary liver cancer | 2 | Celsion (USA - NJ) | Cancer - Oncology |
| 2014-07-28 | masitinib | Gleevec®-resistant gastrointestinal stromal tumor (GIST) | 2 | AB Science (France) | Cancer - Oncology - Rare diseases |
| 2014-07-28 | MOR103 | multiple sclerosis |
1b | MorphoSys (Germany) | Neurodegenerative diseases - Autoimmune diseases |
| 2014-07-25 | DermaPro® | 3 | DermaTools Biotech (Germany) | Metabolic diseases - Cardiovascular diseases | |
| 2014-07-25 | Nexavar® (sorafenib) | advanced breast cancer |
3 | Bayer Healthcare (Germany) Onyx Pharmaceuticals (USA) | Cancer - Oncology |
| 2014-07-25 | duvelisib | follicular lymphoma | 3 | Infinity Pharmaceuticals (USA - MA) | Cancer - Oncology |
| 2014-07-24 | letermovir (MK-8228) | prevention of clinically-significant cytomegalovirus (CMV) infection in adult (18 years and older) CMV-seropositive recipients of allogeneic hematopoietic stem cell transplants |
3 | Merck&Co (USA) Aicuris (Germany) | Infectious diseases |
| 2014-07-24 | MVA-BN Brachyury | advanced cancer |
1 | Bavarian Nordic (Denmark) | Cancer - Oncology |
| 2014-07-24 | MGD007 | colorectal cancer |
1 | Macrogenics (USA - Md) Servier (France) | Cancer - Oncology |
| 2014-07-24 | ThermoDox® (encapsulated doxorubicin) | recurrent chest wall breast cancer |
2 | Celsion (USA - NJ) | Cancer - Oncology |
| 2014-07-23 | MOR106 | preclinical | Galapagos (Belgium) - Morphosys (Germany) | Inflammatory diseases | |
| 2014-07-23 | brivaracetam | epilepsy |
3 | UCB (Belgium) | CNS diseases - Neurological diseases |
| 2014-07-23 | Aplidin® (plitidepsin) in combination with bortezomib and dexamethasone | relapsed and/or refractory multiple myeloma |
1 | PharmaMar (Spain) | Cancer - Oncology - Rare diseases |
| 2014-07-23 | DX-2930 - lanadelumab | hereditary angioedema (HAE) | 1 | Dyax (USA - MA), now Shire (UK - USA) | Rare diseases |
| 2014-07-23 | ATryn® (antithrombin alfa) | preeclampsia |
3 | rEVO Biologics (USA - MA) an LFB Company (France) | Women health |
| 2014-07-22 | Grafix® | chronic diabetic foot ulcer |
Osiris Therapeutics (USA - MD) | Metabolic diseases - Cardiovascular diseases |
